The offering will fund testing of a potential rival to Amgen’s Tezpire and is already the sixth for an immune drug developer this year, the most since 2021.
The company’s upsized offering is a hopeful sign for venture investors in the sector.
As per reports, the Indian markets can expect around 30 IPOs before the end of 2024. The biggest of the lot will be of ...
As September comes to a close, over six companies are gearing up to raise approximately Rs 60,000 crore through initial ...
The initial public offering of Europe’s largest chain of convenience stores, Zabka Group SA, is likely to price at the top of ...
Size, price band, lot size, key dates, GMP, objectives, and more - Everything you need to know about India's largest initial ...
The busiest IPO month of the year, September, is near to its end, but there is no stopping for the IPO frenzy as over a dozen ...
Nasdaq is poised for an IPO market rebound, adding $200 million to revenue. See more on NDAQ stock and why it’s a strong buy ...
Partners Group / Key word (s): Investment Partners Group portfolio company KinderCare prices IPO and lists on New York Stock Exchange 10.10.2024 / 08:00 CET/CEST KinderCare priced its initial ...
(Reuters) - Initial public offerings (IPOs) are slowly coming back in Europe after a summer lull. Polish convenience store ...
Capital markets regulator SEBI has cleared the IPO papers for Hyundai Motor India Ltd. The company plans to launch an IPO of ...
The initial public offering (IPO) of Garuda Construction and Engineering Ltd. was subscribed 7.55 times on its final day of ...